KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Current Deferred Revenue: 2014-2024

  • Opko Health's Current Deferred Revenue fell 14.29% to $6,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $6,000, marking a year-over-year decrease of 14.29%. This contributed to the annual value of $6,000 for FY2024, which is 14.29% down from last year.
  • Per Opko Health's latest filing, its Current Deferred Revenue stood at $6,000 for Q4 2024, which was down 14.29% from $7,000 recorded in Q4 2023.
  • Over the past 5 years, Opko Health's Current Deferred Revenue peaked at $7,000 during Q4 2023, and registered a low of $6,000 during Q4 2024.
  • Moreover, its 2-year median value for Current Deferred Revenue was $6,500 (2023), whereas its average is $6,500.
  • Data for Opko Health's Current Deferred Revenue shows a maximum YoY declined of 14.29% (in 2024) over the last 5 years.
  • Quarterly analysis of 2 years shows Opko Health's Current Deferred Revenue stood at $7,000 in 2023, then dropped by 14.29% to $6,000 in 2024.
  • Its Current Deferred Revenue was $6,000 in Q4 2024, compared to $7,000 in Q4 2023 and $254.1 million in Q3 2015.